Cetirizine
**Cetirizine** is a **second-generation antihistamine** widely used in human medicine and increasingly utilized in veterinary practice for the adjunctive management of allergic and histamine-mediated pruritic (itchy) conditions. * **Non-sedating profile**: Unlike first-generation antihistamines (e.g., diphenhydramine, chlorpheniramine), cetirizine poorly penetrates the blood-brain barrier at standard doses, resulting in significantly less sedation. * **Active metabolite**: It is a piperazine-class derivative and the primary active human metabolite of hydroxyzine. * **Clinical utility**: Primarily used for atopic dermatitis in dogs and cats, adjunctive treatment of chronic rhinosinusitis in cats, and occasionally for allergic conditions in horses. While antihistamines are generally less effective as monotherapy for severe allergic flares in pets compared to humans, they are valuable as part of a multimodal, steroid-sparing approach.
กลไกการออกฤทธิ์: Cetirizine acts as a highly selective, competitive antagonist at peripheral **H1 receptors**. * **Allergic cascade**: Allergen exposure → Mast cell/basophil degranulation → **Histamine** release → Binds to **H1 receptors** on sensory nerve endings and blood vessels → Pruritus, vasodilation, and edema. * Cetirizine competitively blocks this binding, preventing histamine-mediated effects. * It also appears to decrease histamine release from basophils in some species, though experimental studies in cats showed it does not reduce eosinophilic airway inflammation. * It lacks significant anticholinergic or anti-serotonergic activity, and tolerance to its antihistaminic effects is not thought to occur.
ขนาดยาตามชนิดสัตว์
- For adjunctive treatment of non-responsive chronic rhinosinusitis · 5 mg (total dose) PO q12h · PO · q12h
- General antihistamine use · 5 mg (total dose) per cat PO once daily · PO · q24h · No controlled studies evaluating effectiveness against other antihistamines.
- For adjunctive treatment of pruritus · 2.5-5 mg (total dose) per cat once daily · PO · q24h
- Antihistamine · 0.2-0.4 mg/kg PO q12h · PO · q12h · Based on pharmacokinetic and pharmacodynamic data, may be a useful antihistamine in horses.
- For atopic dermatitis · 1 mg/kg PO once daily with or without food · PO · q24h · Satisfactory control of pruritus in 18% of dogs evaluated in the study.
- For atopic dermatitis · 5-10 mg (total dose) PO once daily · PO · q24h
- For allergic dermatitis · 1 mg/kg PO q12h · PO · q12h
- For adjunctive treatment of pruritus · 0.5-1 mg/kg or 5-10 mg total dose once to twice daily · PO · q12-24h
ขนาดยาเป็นข้อมูลอ้างอิงทางคลินิกสำหรับสัตวแพทย์ผู้มีใบอนุญาต โปรดตรวจสอบกับฉลากล่าสุดและผู้ป่วยแต่ละรายเสมอ
วิธีการให้ยา
ข้อห้ามใช้
- Hypersensitivity to cetirizine or hydroxyzine
- Combination products containing pseudoephedrine (e.g., Zyrtec-D) are strictly contraindicated in dogs and cats
อาการไม่พึงประสงค์
- Vomiting
- Hypersalivation (drooling)
- Somnolence (drowsiness/sedation, especially in small dogs at higher dosages)
- Dry mouth (reported in humans)
อันตรกิริยาระหว่างยา
- CNS Depressants · Additive CNS depression if used concurrently with cetirizine · minor
การติดตาม
- Clinical efficacy (reduction in pruritus or allergic signs)
- Adverse effects (vomiting, hypersalivation, somnolence)
การได้รับยาเกินขนาด
Cetirizine generally has a wide margin of safety. * **Massive Overdose**: May cross the blood-brain barrier in overdose situations, leading to neurologic signs (hyperactivity or severe sedation). * **Cardiovascular Safety**: Unlike earlier non-sedating antihistamines (terfenadine and astemizole), cetirizine does not appreciably prolong the QT interval on ECG at high serum levels. * > **TOXICITY ALERT**: Overdoses of cetirizine products that also contain pseudoephedrine (e.g., Zyrtec-D 12 Hour) are highly dangerous and potentially fatal. Immediate veterinary intervention and consultation with an animal poison control center are required.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต